National Bank of Canada FI Buys 320,924 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

National Bank of Canada FI increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 262.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 443,248 shares of the company’s stock after purchasing an additional 320,924 shares during the period. National Bank of Canada FI owned approximately 0.10% of GE HealthCare Technologies worth $34,661,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Cathy Pareto & Associates Inc. bought a new position in shares of GE HealthCare Technologies during the fourth quarter worth about $670,000. Principal Financial Group Inc. boosted its position in GE HealthCare Technologies by 1.9% during the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock worth $94,780,000 after acquiring an additional 19,010 shares during the last quarter. Everence Capital Management Inc. raised its holdings in shares of GE HealthCare Technologies by 118.2% in the fourth quarter. Everence Capital Management Inc. now owns 18,870 shares of the company’s stock valued at $1,475,000 after purchasing an additional 10,220 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its position in shares of GE HealthCare Technologies by 9.7% in the third quarter. Nomura Asset Management Co. Ltd. now owns 145,996 shares of the company’s stock worth $13,702,000 after purchasing an additional 12,908 shares in the last quarter. Finally, Apollon Wealth Management LLC lifted its position in shares of GE HealthCare Technologies by 46.5% in the fourth quarter. Apollon Wealth Management LLC now owns 13,111 shares of the company’s stock worth $1,025,000 after purchasing an additional 4,160 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 0.3 %

Shares of GEHC opened at $79.36 on Thursday. The firm has a market cap of $36.29 billion, a P/E ratio of 18.33, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The firm’s 50-day simple moving average is $86.30 and its 200 day simple moving average is $85.71.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.18%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies’s payout ratio is 3.23%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on GEHC shares. Citigroup lifted their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their target price for the company from $85.00 to $100.00 in a research report on Tuesday, March 11th. Wells Fargo & Company increased their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, February 14th. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $97.73.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.